Skip to content
Avodart

Avodart

Active ingredient: Dutasteride

Package

AED 338.30

AED 489.54 AED 507.45 Save 4%

AED 915.40 AED 1,014.90 Save 10%

AED 1,345.24 AED 1,522.35 Save 12%

AED 1,771.10 AED 2,029.80 Save 13%

AED 2,634.76 AED 3,044.70 Save 13%

AED 3,920.30 AED 4,567.05 Save 14%

AED 4,692.42 AED 6,089.40 Save 23%

Free delivery on orders from AED 796.00, free express delivery from AED 1,194.00

Delivery: from 4 days

Avodart contains dutasteride, a 5-alpha-reductase inhibitor used mainly for an enlarged prostate. It lowers dihydrotestosterone, helping reduce prostate stimulation over time rather than providing immediate urinary relief.

Product information

Benign prostatic hyperplasia can cause a weak stream, frequent urination, and incomplete bladder emptying.

How it affects the body

Dutasteride acts on the hormonal pathway that supplies DHT to prostate tissue and other androgen-sensitive tissues. It inhibits both major 5-alpha-reductase enzyme types, giving it broader enzyme coverage than medicines that mainly target Type 2.

DHT Production and Enzyme Blockade

Testosterone is converted into DHT through the action of 5-alpha-reductase. Dutasteride restricts this conversion by inhibiting Type 1 and Type 2 enzymes. DHT is a potent androgen, but it is not harmful in every tissue; its role depends on the organ, age, hormone environment, and underlying condition.

The resulting antiandrogenic activity means reduced DHT signalling. It does not eliminate testosterone, stop all androgen activity, or act as a general hormone blocker.

Prostate Response to Lower DHT

Prostate cells respond to lower DHT stimulation over time. This can reduce prostate tissue volume and ease obstruction around the urethra. Symptom improvement may take several weeks or months, and the result varies with prostate size, bladder function, and the presence of other urinary conditions.

Ingredients

Composition and Pharmacological Class

Avodart contains dutasteride, an active substance that blocks both Type 1 and Type 2 5-alpha-reductase enzymes. These enzymes convert testosterone into dihydrotestosterone, also called DHT. Lower DHT levels can reduce prostate growth and improve symptoms linked to benign prostatic hyperplasia.

Avodart is supplied as a soft capsule for oral use.

The capsule should be swallowed whole. Its established prostate-related use is different from hair-loss treatment, where dutasteride may be prescribed off-label in some jurisdictions.

The drug class has a gradual effect. Dutasteride remains in the body for a prolonged period, so both benefits and adverse effects may continue after treatment stops.

Avodart does not work like a rapid urinary-relief medicine. A person who expects immediate improvement after the first few doses may stop too early.

Dosage and administration

The amount and frequency of Avodart depend on the purpose of use and are agreed with a doctor or pharmacist. For benign prostatic hyperplasia, adult treatment is commonly prescribed as one capsule once daily under the applicable product directions.

Usual Adult Administration

  • Swallow the soft capsule whole with water.
  • Take it at approximately the same time each day.
  • Do not crush, chew, open, or puncture the capsule.
  • Do not change the dose for hair loss or urinary symptoms without a prescriber’s direction.
  • Continue treatment consistently unless the prescriber changes or stops it.

Avodart may be taken with food or on an empty stomach.

A regular time makes missed doses less likely, but it does not make the medicine act faster.

Missed Dose and Practical Administration Errors

If a dose is missed, take it when remembered unless the next scheduled dose is close. Do not take two capsules together to compensate. If two doses are missed, resume the usual schedule rather than trying to catch up.

Stopping because urination improves is another common mistake. The underlying prostate enlargement may remain, and symptoms can return after treatment is withdrawn.

A leaking capsule should not be handled casually. Wash the affected skin with soap and water, and keep the contents away from pregnant women or anyone who could become pregnant.

When not to use it

Avodart is not suitable for everyone. The product requires careful review in the following situations:

  • Pregnancy or the possibility of pregnancy
  • A history of allergy to dutasteride or related 5-alpha-reductase inhibitors
  • Severe liver disease or unexplained abnormal liver tests
  • Unexplained breast changes
  • Urinary retention or blood in the urine requiring diagnostic assessment
  • Treatment with medicines that strongly inhibit CYP3A4 or P-glycoprotein
  • Use of another 5-alpha-reductase inhibitor unless specifically prescribed

Liver impairment can increase dutasteride exposure because the medicine is extensively metabolised in the liver. The prescriber may need to select a different approach or arrange closer monitoring.

When this is not for you

Avodart may not be for you if you are pregnant, have a relevant allergy, severe liver disease, or need urgent assessment for urinary retention or blood in the urine.

Give the prescriber a complete list of medicines, supplements, and herbal products before starting Avodart. Interaction screening should include medicines used only occasionally, such as treatments for infections or fungal disease.

Possible side effects

Avodart Side Effects, Warnings, and Precautions

Avodart is tolerated by many patients, but dutasteride can affect sexual function and reproductive parameters. Regulatory product information identifies reduced libido, erectile difficulties, ejaculation changes, and breast-related symptoms among possible adverse effects [1].

Common Sexual and Hormonal Effects

Possible effects include:

  • Reduced sexual desire
  • Difficulty achieving or maintaining an erection
  • Changes in ejaculation
  • Reduced semen volume
  • Breast tenderness or breast enlargement
  • Reduced sperm count or altered semen characteristics in some men

These effects do not occur in every patient. Some continue after discontinuation, although the long-term pattern varies. Persistent breast pain, a breast lump, or nipple discharge needs prompt medical assessment because not every breast symptom is caused by dutasteride.

Mood changes also deserve attention. New depression, severe anxiety, or thoughts of self-harm require urgent medical support.

Urgent Reactions and Longer-Term Precautions

Seek urgent care for facial or throat swelling, breathing difficulty, widespread blistering, skin peeling, or a severe allergic reaction. These symptoms can indicate angioedema or a serious skin reaction.

Dutasteride lowers prostate-specific antigen, or PSA, readings. A clinician interpreting PSA results must know that the patient uses Avodart, because a reduced reading does not eliminate prostate-cancer risk. A rising or unexpectedly changed PSA still requires clinical evaluation.

Avodart is not intended for women or children. Dutasteride can be absorbed through the skin from a leaking capsule. Pregnant women or women who could become pregnant should not handle leaking capsules, because exposure to dutasteride may affect development of a male fetus. Dutasteride can also be detected in semen; condom use may be discussed when a partner is pregnant or could become pregnant.

Blood donation restrictions apply during treatment and for a period after the final dose because dutasteride remains in the body. The applicable interval should be confirmed with the blood service or prescribing team.

Therapeutic indications

Approved Prostate-Related Use

Avodart is used for benign prostatic hyperplasia, a non-cancerous enlargement of the prostate. Lower DHT exposure can reduce prostate volume and improve lower urinary tract symptoms such as urgency, weak flow, night-time urination, and straining.

Treatment may also lower the likelihood of acute urinary retention and reduce the need for prostate-related surgery in appropriate patients. The improvement develops gradually because the prostate needs time to respond to reduced hormonal stimulation. Dutasteride does not remove the need to investigate blood in the urine, painful urination, fever, or sudden inability to urinate.

Avodart and Hair Growth Evidence

Dutasteride may be prescribed off-label for androgenetic alopecia, also called androgenic alopecia or male pattern hair loss. DHT can contribute to follicle miniaturisation in genetically sensitive scalp areas. By lowering DHT, dutasteride may help preserve or increase hair density for some men.

The strongest potential response is usually discussed for the crown and central scalp. Hairline response is less predictable. Eyebrow growth is not an established standard outcome for Avodart.

Androgenetic Alopecia and DHT Sensitivity

Not every pattern of shedding is caused by DHT. Thyroid disease, iron deficiency, inflammatory scalp disorders, medication effects, rapid weight loss, and significant illness can produce diffuse hair loss. A dermatological assessment helps distinguish androgenetic alopecia from these conditions.

Evidence for dutasteride in hair loss is less aligned with its established prostate indication. Treatment may require months of consistent use, and continued exposure is generally needed to maintain any benefit. Stronger DHT suppression does not guarantee a better personal result.

Off-Label Hair-Loss Treatment Expectations

Hair-loss use may be outside the approved indication depending on the jurisdiction and local product information. A prescriber may consider it after assessing the hair-loss pattern, reproductive plans, liver health, current medicines, and the possibility of DHT-related side effects.

Dutasteride may improve density in some men, while others see limited change or no meaningful regrowth. Photographs taken under consistent lighting are more useful than daily mirror checks, since normal shedding can obscure gradual changes.

Comparison

Avodart Compared With Finasteride

Finasteride and dutasteride both reduce DHT, but they differ in enzyme coverage and pharmacokinetic persistence. The choice depends on the prostate condition, hair-loss indication, medical history, adverse-effect tolerance, and local approval.

Treatment Main enzyme effect Common clinical context
Dutasteride Inhibits Type 1 and Type 2 5-alpha-reductase Benign prostatic hyperplasia; hair-loss use may be off-label
Finasteride Mainly inhibits Type 2 5-alpha-reductase Benign prostatic hyperplasia or androgenetic alopecia, depending on strength and approval

Dutasteride can produce broader DHT suppression than finasteride because it acts on both enzyme types. That may help some patients, though it can also increase concern about sexual, reproductive, or hormonal adverse effects. Dutasteride also persists longer in the body, so a treatment change does not produce an immediate change in exposure.

Some research has compared higher study doses of dutasteride with finasteride. Those research protocols do not establish self-dosing instructions for Avodart. A study result should never be converted into an individual treatment plan without a prescriber’s assessment.

Common mistakes

Several practical errors can reduce benefit or increase risk:

  • Taking an extra capsule after a missed dose
  • Crushing, chewing, or opening the soft capsule
  • Stopping as soon as urination improves
  • Treating sudden urinary retention with Avodart instead of seeking urgent care
  • Forgetting to mention Avodart before PSA testing
  • Handling a leaking capsule during pregnancy exposure
  • Assuming hair growth will be immediate
  • Using Avodart for hair loss without checking for thyroid disease, iron deficiency, or other causes
  • Combining dutasteride with finasteride without a prescriber’s instruction
  • Failing to report breast lumps, severe mood changes, or allergic symptoms

One practical detail matters: daily shedding is a poor measure of hair-treatment response. Hair grows in cycles, so consistent photographs over several months provide a more useful comparison than counting hairs in a shower drain.

What doctors say

A clinician usually sets expectations early: Avodart is a long-term prostate treatment, not an instant urinary remedy. Symptom improvement depends on prostate size, bladder function, baseline obstruction, and whether another medicine is needed for faster symptom control.

The PSA issue is easy to miss. Any clinician ordering or interpreting PSA testing needs to know about dutasteride use, including treatment started for hair loss. A lower PSA value must be interpreted in context rather than treated as proof that prostate disease has been excluded.

For androgenetic alopecia, a dermatologist will usually confirm the pattern of hair loss before considering off-label dutasteride. Thyroid testing, iron assessment, scalp examination, or other investigations may be appropriate when shedding is diffuse or sudden. The European Medicines Agency and national medicines authorities describe dutasteride’s reproductive and hormonal precautions in product information [2].

Common questions

How long does an Avodart course last, and is long-term use acceptable?

Avodart is commonly used as a long-term treatment for benign prostatic hyperplasia rather than as a short course. The acceptable duration depends on symptom control, prostate assessment, PSA interpretation, liver health, and adverse effects. NICE guidance published in 2024 supports ongoing review of lower urinary tract treatment rather than automatic continuation without assessment. Long-term use is acceptable for suitable patients when the prescriber continues to judge that the benefits outweigh the disadvantages.

Can Avodart cause sexual side effects?

Yes, dutasteride can cause reduced libido, erectile difficulty, ejaculation changes, or reduced semen volume. The FDA's 2024 prescribing information describes these effects as recognised risks, and they do not affect every patient. Symptoms may continue for some time after stopping because dutasteride leaves the body slowly. A persistent or distressing change needs a medication review rather than an unsupervised dose adjustment.

What happens after stopping Avodart, and does it need tapering?

Avodart does not usually require tapering because it has a long half-life and leaves the body gradually. Urinary symptoms may return if prostate enlargement remains untreated, while any hair-loss benefit may fade over time after treatment stops. FDA's 2024 product information describes prolonged dutasteride elimination, which explains why effects can persist after discontinuation. The reason for stopping matters, especially if the medicine was stopped because of a serious reaction.

Can Avodart be taken with food or on an empty stomach?

Avodart can generally be taken with food or without food. The EMA's 2023 product information describes oral administration without requiring a specific meal relationship. Taking it at a consistent time can help prevent missed doses, but food does not make the medicine act immediately. If nausea or stomach discomfort occurs, the prescribing team can review the timing and the wider medication list.

Can the Avodart capsule be split, crushed, or chewed?

No. The soft capsule should be swallowed whole because opening or damaging it can expose the skin to dutasteride and may alter how the dose is handled. The WHO’s 2023 medication-safety resources support using dosage forms according to their intended route and handling instructions. Anyone who has contact with leaking capsule contents should wash the skin promptly, with special care around pregnancy exposure.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Avodart Current

Active ingredient: Dutasteride
0.5mg
From AED 338.30
pills
4.3 (5)

Himplasia

Active ingredient: Himplasia
30caps
From AED 405.96
bottles
3.9 (4)

Comparison table: Enlarged Prostate

Sources

  1. U.S. Food and Drug Administration (2024). Avodart (dutasteride) capsules prescribing information.
  2. European Medicines Agency (2023). Dutasteride: product information and safety information.

How Buyers Rate Avodart

4.3 Based on 5 reviews
Ali, 37 Al Qusais Several months
6 Nov 2026
Rating: 5 out of 5
I used Avodart consistently for several months for urinary symptoms. Night-time trips became less disruptive, and the stream felt stronger. The change was gradual, but the improvement was clear enough to make the routine worthwhile.
Rashid, 47 Al Khawaneej
12 Nov 2026
Rating: 5 out of 5
I took one capsule daily and noticed that starting urination became easier after some time. I did not expect an immediate result, which helped me stay consistent. My day felt less organised around finding a bathroom.
Arjun H., 49 Fujairah
15 Oct 2026
Rating: 3.5 out of 5
Avodart helped reduce urgency, but the improvement was slower than I expected. I also noticed lower sexual interest during treatment, which was a reservation for me. The urinary benefit was real, though it did not outweigh the concern without a further medical discussion.
Joel, 35 Deira Several months
21 Oct 2026
Rating: 5 out of 5
I used dutasteride for gradual crown thinning and saw better density after several months. The hairline changed less than the crown. I was satisfied with the progress because I had kept realistic expectations from the start.
Yousef, 55 Al Ain A sustained trial
28 Oct 2026
Rating: 3 out of 5
My urinary symptoms improved only partly after a sustained trial. I also experienced ejaculation changes, so I stopped and discussed the next option with my doctor. The medicine was not a good fit for me, even though the treatment had a reasonable purpose.
Get our free app Shop faster and track your orders 4.0 · 268 reviews Install